Clinical Trials

NCT Number: NCT06347705 Phase: PHASE2 Trial Summary: The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system t – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): MidLantic Urology Acronym:

NCT Number: NCT06369610 Phase: PHASE2 Trial Summary: This phase II trial tests how well risk based de-escalated hormone therapy (i.e., fewer treatments) with radiation works in treating patients with prostate cancer. Androgen deprivation therapy (ADT), – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic Acronym:

NCT Number: NCT06378346 Phase: PHASE2 Trial Summary: This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy) – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Illinois at Chicago Acronym: GU-01

NCT Number: NCT06190899 Phase: PHASE1|PHASE2 Trial Summary: This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combination with darolutamide in subjects with – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Celcuity Inc Acronym:

NCT Number: NCT05946824 Phase: PHASE2 Trial Summary: There is significant, proven use of radiation for recurrent prostate cancer after surgical resection. This treatment typically is delivered over seven and a half weeks of daily treatments, presenting – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Celcuity Inc Acronym: DASBRT-RPC

NCT Number: NCT05988918 Phase: PHASE2 Trial Summary: This protocol will enroll patients with pancreatic adenocarcinoma and adenosquamous carcinoma (Cohort 1), gastrointestinal/pancreatic neuroendocrine neoplasms with Ki-67 > 20% (Cohort 2) and neuroend – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Michigan Rogel Cancer Center Acronym:

NCT Number: NCT06044025 Phase: PHASE1 Trial Summary: The goal of this clinical trial is to assess the feasibility of adding a combination of metformin and turmeric as part of a nutritional intervention regimen to the current standard of care, namely, in – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Arkansas Acronym:

NCT Number: NCT06049355 Phase: PHASE2 Trial Summary: This phase II trial tests how well an exercise intervention, Exercising Together, works in preventing declines in physical and mental health in couples during radiation treatment for cancer. Treatment – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Fusion Pharmaceuticals Inc. Acronym:

NCT Number: NCT06066437 Phase: PHASE1|PHASE2 Trial Summary: To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androg – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial […]

NCT Number: NCT06067269 Phase: PHASE2 Trial Summary: This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate cancer. Prostate cancer usually needs – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Jonsson Comprehensive Cancer Center Acronym: HEATWAVE